How Molekula Sources Hard-to-Find Specialty Chemicals
Molekula sources hard-to-find specialty chemicals through direct partnerships with niche manufacturers, rigorous quality control using HPLC, GC-MS, and NMR, and compliance with ISO, REACH, and USP standards. All materials are supplied with full CoA and SDS, ensuring traceability and regulatory alignment.
Available from Molekula
These are available from Molekula. See specifications, pack sizes and pricing, or ask us for a quote.
-
View product
Coenzyme A free acid
CAS 85-61-0 · C21H36N7O16P3S -
View product
Coenzyme A, trilithium salt
CAS 18439-24-2
Molekula secures hard-to-find specialty chemicals by establishing direct procurement channels with small-scale and specialised manufacturers, particularly in regions with strong chemical R&D infrastructure. This approach enables access to compounds with limited commercial availability, including custom-synthesised intermediates and low-volume reagents. Each batch undergoes strict quality verification using HPLC, GC-MS, and NMR to confirm identity and purity, with results documented in a Certificate of Analysis (CoA). All products comply with relevant regulatory frameworks, including REACH, TSCA, and ISO 9001, and are available with full Safety Data Sheets (SDS) and traceable documentation.
What types of specialty chemicals does Molekula source?
Molekula sources a range of high-purity, low-volume specialty chemicals, including chiral building blocks, rare metal complexes (e.g., Pd(0) catalysts), custom peptides, and synthetic intermediates for pharmaceutical and biotech applications. These include compounds with specific stereochemistry, such as (S)-2-amino-3-phenylpropanoic acid (CAS 1000-27-5), and sensitive reagents like TCEP (tris(2-carboxyethyl)phosphine) for disulphide reduction in protein work. Availability is often limited due to low production volumes or complex synthesis pathways, making direct sourcing from manufacturers essential.
How does Molekula ensure quality and consistency?
Quality assurance is maintained through a multi-tiered verification process. Every batch is tested using HPLC (with UV/ELSD detection) to assess purity, GC-MS for volatile impurities, and NMR (1H and 13C) for structural confirmation. For biological reagents, additional assays such as ELISA or PCR are used where applicable. All results are compiled into a CoA, which includes lot number, date of manufacture, expiry, and test method details. Compliance with ISO 9001:2015 and ISO 17025 accreditation ensures method reliability. For pharmaceutical-grade materials, USP, BP, and EP monographs are referenced where available.
What regulatory frameworks does Molekula comply with?
Molekula ensures compliance with key international regulations. All products are registered under REACH (EC No. and CAS number traceable), and those imported into the US are listed under TSCA. GHS-compliant SDS are provided for all chemicals, detailing hazard classification, safe handling, and disposal. For pharmaceutical and diagnostic applications, materials are supplied to meet USP, BP, and EP specifications where applicable. Traceability is maintained through batch-specific documentation, including raw material origin and manufacturing site details.
How does Molekula manage supply chain risks for rare chemicals?
Supply chain resilience is achieved through diversified sourcing, strategic inventory management, and long-term contracts with primary suppliers. For chemicals with limited availability, Molekula maintains a small buffer stock of critical reagents (e.g., DTT, EDTA, HEPES) to mitigate disruption. Supplier audits are conducted annually to verify compliance with quality and environmental standards. In cases of supply interruption, alternative synthesis routes or equivalent reagents are evaluated and validated prior to substitution. All changes are documented and communicated to customers via update notices.
Sources
- European Chemicals Agency (ECHA). REACH Regulation (EC) No 1907/2006.
- U.S. Environmental Protection Agency (EPA). TSCA Inventory.
- International Organization for Standardization (ISO). ISO 9001:2015 Quality Management Systems.
- United States Pharmacopeia (USP). USP-NF Monographs.
- British Pharmacopoeia (BP). BP 2022.
- European Pharmacopoeia (EP). EP 11.0.
Frequently asked
-
Q: Are Molekula’s specialty chemicals suitable for GMP applications? A: Yes, where specified. Materials meeting USP, BP, or EP standards are available for GMP use. Full CoA and traceability documentation are provided.
-
Q: Can I request a custom synthesis? A: Molekula partners with custom synthesis providers for niche compounds. Contact the technical team with specifications (CAS, structure, purity, quantity).
-
Q: How quickly can Molekula source a rare reagent? A: Delivery depends on synthesis complexity. Standard requests (e.g., TCEP, DTT) are fulfilled within 5–7 working days; custom syntheses may take 4–12 weeks.
-
Q: Do you provide analytical data for every batch? A: Yes. Each batch includes a CoA with HPLC, GC-MS, and/or NMR data, as applicable. Full analytical reports are available on request.
Frequently asked
Are Molekula’s specialty chemicals suitable for GMP applications?
Yes, where specified. Materials meeting USP, BP, or EP standards are available for GMP use. Full CoA and traceability documentation are provided.
Can I request a custom synthesis?
Molekula partners with custom synthesis providers for niche compounds. Contact the technical team with specifications (CAS, structure, purity, quantity).
How quickly can Molekula source a rare reagent?
Delivery depends on synthesis complexity. Standard requests (e.g., TCEP, DTT) are fulfilled within 5–7 working days; custom syntheses may take 4–12 weeks.
Do you provide analytical data for every batch?
Yes. Each batch includes a CoA with HPLC, GC-MS, and/or NMR data, as applicable. Full analytical reports are available on request.
Related reading
-
Supplier-news
Sourcing High‑Purity Rare Isotopes for Radiopharmaceuticals Amid Global Shortages
High‑purity rare isotopes for radiopharmaceuticals can still be sourced despite worldwide shortages by diversifying suppliers, using alternative production routes, and implementing strict quality‑control protocols. Key actions include engaging multiple certified manufacturers, verifying ISO/REACH compliance, and maintaining a validated inventory management system.
Oct 2, 2026 · 5 min read -
Supplier-news
Evaluating the Resilience of African API Hubs After Recent Trade Disruptions
African active pharmaceutical ingredient (API) hubs have shown mixed resilience to recent trade disruptions. While some hubs have maintained output through local sourcing and inventory buffers, others face capacity constraints due to import delays, logistics bottlenecks and regulatory challenges, as highlighted by UNCTAD and Afreximbank analyses.
Sep 20, 2026 · 4 min read -
Supplier-news
Supplier qualification checklist for GMP‑grade isotopically labelled compounds in 2026
A robust supplier qualification checklist for GMP‑grade isotopically labelled compounds in 2026 must verify regulatory compliance (ISO 9001:2015, ISO 13485, GMP, REACH, TSCA), assess quality systems, confirm analytical capability (NMR, HPLC, GC‑MS), and evaluate documentation such as CoA, SDS and audit history.
Sep 19, 2026 · 4 min read -
Supplier-news
Strategic sourcing of rare earth catalysts amid geopolitical tensions in 2026
Rare earth catalysts remain essential for fine‑chemical and biopharmaceutical processes, but 2026 geopolitical tensions have tightened supply chains. China still supplies the majority, while export controls and trade disputes increase lead times and price volatility. Diversified sourcing, recycling, and alternative chemistries are the primary risk‑mitigation strategies.
Aug 27, 2026 · 4 min read